Although African American women have a lower incidence of. Histologic Grade, Stage, and Survival in Breast Carcinoma
|
|
- Matthew Pope
- 5 years ago
- Views:
Transcription
1 908 Histologic Grade, Stage, and Survival in Breast Carcinoma Comparison of African American and Caucasian Women Donald Earl Henson, M.D. 1 Kenneth C. Chu, Ph.D. 2 Paul H. Levine, M.D. 3 1 Department of Pathology, Office of Cancer Prevention and Control, The George Washington University Cancer Institute, Washington, DC. 2 Center to Reduce Cancer Health Disparities, National Cancer Institute, Bethesda, Maryland. 3 Department of Epidemiology and Biostatistics, The George Washington University School of Public Health and Health Services, Washington, DC. Supported by the Komen Foundation. Address for reprints: Donald Earl Henson, M.D., Department of Pathology, The George Washington University Medical Center, Ross Hall, Room 502, 2300 I Street, NW, Washington DC, 20037; Fax: (202) ; patdeh@gwumc.edu Received March 13, 2003; revision received May 1, 2003; accepted May 7, The opinions expressed herein do not necessarily reflect the views of the National Cancer Institute or the U. S. Government. *This article is a US Government work and, as such, is in the public domain in the United States of America. BACKGROUND. African American women have lower breast carcinoma survival rates than do Caucasian women. African American women often present with advanced-stage disease and more aggressive tumors as shown by histologic and laboratory-based prognostic factors. Aggressive tumor behavior may be responsible, at least in part, for the advanced stage and reduced survival rates. METHODS. The authors investigated the correlation between survival and histologic grade, stage of disease, and tumor size for both African American and Caucasian women who were younger than age 50 years and age 50 years and older. The authors also investigated the distribution of grade within each stage group and the distribution of grade by tumor size. African American and Caucasian women were matched by stage, tumor size, and histologic grade. Survival was represented by 6-year breast carcinoma specific survival rates. RESULTS. Compared with Caucasian women, African American women, regardless of age, had proportionally more Grade III tumors and fewer Grade I and II tumors for all stages combined and for each individual stage group. Similarly, matched for tumor size, African American women had more Grade III tumors and fewer Grade I and II tumors compared with Caucasian women, except for tumors smaller than 1.0 cm. For nearly all combinations of stage and grade regardless of age, the 6-year breast carcinoma specific survival rate was lower for African American women than for Caucasian women, although it did not always reach statistical significance. CONCLUSIONS. Compared with Caucasian women, African American women, regardless of age, presented with proportionally more aggressive tumors for each stage of disease and for each tumor size above 1.0 cm as revealed by the histologic grade. Higher histologic grade may be a significant contributing factor to survival disadvantage for African American women. Cancer 2003;98: Published 2003 by the American Cancer Society.* KEYWORDS: breast carcinoma, race, survival, histologic grade, stage, tumor size, African American women, Caucasian women. Although African American women have a lower incidence of breast carcinoma than Caucasian women (100.2 cases per 100,000 and cases per 100,000, respectively), African American women have a less favorable outcome than Caucasian women stage for stage. According to the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute, the 5-year survival rates, all stages combined, for African American and Caucasian women are 69.0% and 84.4%, respectively. 1 Further evidence for this survival disadvantage is based on institutional studies of racial differences in outcome. 2,3 Published 2003 by the American Cancer Society* DOI /cncr.11558
2 Racial Differences in Histologic Grade/Henson et al. 909 FIGURE 1. Comparison of the proportional distribution of histologic grade for Caucasian women (white bars) and African American women (blue bars) younger than age 50 years, for all stages combined and for each stage. Patients were staged according to the American Joint Committee on Cancer TNM classification. Socioeconomic status (SES), lack of access to medical care, less utilization of screening, variations in treatment, comorbid conditions, lack of compliance with treatment recommendations, and late stage presentation have all been offered as explanations for the lower survival rates among African American women. 4 8 Although SES, even more than race, is considered by many the most important predictor of outcome, 5,9,10 studies continue to show that African American women present with more aggressive breast tumor types compared with Caucasian women In the current study, we investigated histologic grade as it relates to stage of disease, tumor size, and survival between African American and Caucasian women using data from the SEER program. The results indicate that aggressive tumor behavior as revealed by histologic grade should also be taken into account in studies on disparity. MATERIALS AND METHODS Data were obtained from the SEER program for the period January 1992 to December SEER covers 11 geographic areas: Atlanta, GA; Connecticut; Detroit, MI; Hawaii; Iowa; Los Angeles, CA; New Mexico; San Francisco Oakland, CA; San Jose Monterey, CA; Seattle Puget Sound; and Utah. These areas include approximately 12% of the U.S. population and represent national demographic patterns. Population based from inception, SEER has accrued data since 1973 in most survey areas through regional and statewide tumor registries. 1 Six-year cause-specific survival rates were calculated using death certificate data that listed breast carcinoma as the underlying cause of death. These disease-specific survival rates and standard errors were calculated for African American and Caucasian women using the SEER Public Use CD-ROM, 1973
3 910 CANCER September 1, 2003 / Volume 98 / Number 5 FIGURE 2. Comparison of the proportional distribution of histologic grade for Caucasian women (white bars) and African American women (blue bars) age 50 years and older, for all stages combined and for each stage grouping. Patients were staged according to the American Joint Committee on Cancer TNM classification. 1999, with its SEER*Stat 4.2 computer program. In situ cases (Stage 0) were excluded from the analysis. The number of cases recorded for each combination of grade and stage is listed in Tables 1 4. In the current study, Caucasian is used synonymously with white. All other racial/ethnic groups were omitted except for African American women. Staging was based on the TNM classification as published by the American Joint Committee on Cancer (AJCC) with four stages (Stages I IV). 14 Stage IV survival rates could not be determined for each grade for African American women. Histologic grade and tumor size were recorded from pathology reports. There were 4 categories for tumor size (i.e., 1.0 cm, cm, cm, and 5.1 cm, which corresponds to AJCC staging). To evaluate the effect of age, the study population was divided into 2 groups (younger than age 50 years and age 50 years and older). Methods for the statistical analyses of differences in stage distributions and differences in survival rates between Caucasian and African American women have been reported. 15 Corrections for multiple comparisons were used. RESULTS Distribution of Histologic Grade by American Joint Committee on Cancer Stage Figure 1 compares the grade distribution for African American and Caucasian women (younger than age 50 years) for Stages I IV combined, and for each individual stage, excluding cases of unknown grade. In general, Caucasian women had proportionally more Grade I and II tumors whereas African American women had a higher proportion of Grade III tumors for all stages combined and for each stage group. Figure 2 shows the distribution of grade for women
4 Racial Differences in Histologic Grade/Henson et al. 911 TABLE 1 Comparison of 6-Year Breast Carcinoma Survival Rates by Race, Grade, and American Joint Committee on Cancer Stage for Women Younger than Age 50 Years No. of patients 6-yr survival rate No. of White Black White Black Black/White survival rate difference AJCC Stages I IV Grade I IV 20, a Grade I Grade II a Grade III a Grade IV Unknown AJCC Stage I Grade I IV a Grade I Grade II Grade III Grade IV Unknown AJCC Stage II Grade I IV a Grade I Grade II a Grade III a Grade IV Unknown AJCC Stage III Grade I IV a Grade I Grade II Grade III a Grade IV Unknown AJCC Stage IV Grade I IV a Grade I 13 4 na na Grade II Grade III a Grade IV na na Unknown AJCC: American Joint Committee on Cancer; na: not available. a P value (two-sided) 0.01 (0.05/5). (age 50 years and older) for Stages I IV combined and for each stage. Again, African American women had proportionally more Grade III tumors and proportionally fewer Grade I and II tumors than Caucasian women did. For all stages combined (Figs. 1, 2), African American women had a significantly higher proportion of Grade III tumors than Caucasian women in both age groups. For Caucasian women younger than age 50 years, the proportion of Grade III tumors was significantly higher than the proportion of Grade II tumors. In contrast, for Caucasian women age 50 years and older, the proportion of Grade III tumors was significantly less than the proportion of Grade II tumors. However, this pattern was not seen among African American women. Among African American women age 50 years and older, the proportion of Grade III tumors was significantly higher than the proportion of Grade II tumors. Stage, Histologic Grade, and Survival For each combination of grade and stage, the 6-year disease-specific survival rate for African American
5 912 CANCER September 1, 2003 / Volume 98 / Number 5 TABLE 2 Comparison of 6-Year Breast Carcinoma Survival Rates by Race, Grade, and American Joint Committee on Cancer Stage for Women Age 50 Years and Older No. of patients 6-yr survival rate White Black White Black Black/White survival rate difference AJCC Stages I IV Grade I IV 58, a Grade I 11, a Grade II 26, a Grade III 19, a Grade IV Unknown 14, AJCC Stage I Grade I IV 31, a Grade I Grade II 14, a Grade III Grade IV a Unknown AJCC Stage II Grade I IV 21, a Grade I Grade II a Grade III a Grade IV Unknown AJCC Stage III Grade I IV a Grade I a Grade II Grade III Grade IV na na Unknown AJCC Stage IV Grade I IV Grade I na na Grade II Grade III Grade IV na na Unknown AJCC: American Joint Committee on Cancer; na: not available. a P value (two-sided) 0.01 (0.05/5). women younger than age 50 years was consistently lower than that for Caucasian women (Table 1). Although this observation did not reach statistical significance for every combination of grade and stage, it was observed in 11 of the 14 combinations that were analyzed (Table 1). The difference in survival was significantly smaller for African American women for Grade II and III tumors in Stages I IV combined (Table 1). It also was significantly smaller for all grades and stages combined (Table 1). African American women had significantly lower survival rates for Grade II and III tumors in Stage II, Grade III tumors in Stage III, and for Grade III tumors in Stage IV. For each combination of grade and stage, the 6-year disease-specific survival rate for African American women age 50 years and older was consistently lower than that for Caucasian women (Table 2). This difference did not reach statistical significance for every combination of grade and stage, but it was observed in 12 of the 13 combinations that were analyzed (Table 2). The difference in survival was significantly less for African American women for Grade II tumors in Stage I, for Grade II and III tumors in Stage II, and for Grade I tumors in Stage III (Table 2). It was also significant for all grades and stages combined.
6 Racial Differences in Histologic Grade/Henson et al. 913 FIGURE 3. Comparison of the proportional distribution of histologic grade for Caucasian women (white bars) and African American women (blue bars) younger than age 50 years, according to the size of the primary tumor. FIGURE 4. Comparison of the proportional distribution of histologic grade for Caucasian women (white bars) and African American women (blue bars) age 50 years and older, according to the size of the primary tumor. Distribution of Histologic Grade by Tumor Size The distribution of grade evaluated in correlation to tumor size is shown in Figures 3 and 4. For every size except tumors smaller than 1.0 cm, African American women had significantly more Grade III tumors in both age groups than did Caucasian women. Figures 3 and 4 also indicate that grade increases with tumor size in both African American and Caucasian women, regardless of age. For instance, for tumor size cm in women younger than age 50 years, 42% and 57% of Caucasian and African American women, respectively, had Grade III tumors. For tumor sizes 5.1 cm or larger, 63% of Caucasian women had Grade III tumors, compared with 78% of African American women. A similar observation was made for women age 50 years and older. Tumor Size, Histologic Grade, and Survival Tables 3 and 4 show, respectively, the 6-year breast carcinoma specific survival rates for each combination of tumor size and grade for women younger than
7 914 CANCER September 1, 2003 / Volume 98 / Number 5 TABLE 3 Comparison of 6-Year Breast Carcinoma Survival Rates by Race, Grade, and Tumor Size for Women Younger than Age 50 Years No. of patients 6-yr survival rate White Black Whites Blacks Black/White survival rate difference Tumor size 1.0 cm Grade I IV Grade I Grade II Grade III Grade IV na na Unknown Tumor size cm Grade I IV a Grade I Grade II a Grade III a Grade IV Unknown Tumor size cm Grade I IV a Grade I Grade II Grade III a Grade IV Unknown Tumor size 5.1 cm Grade I IV a Grade I Grade II Grade III a Grade IV Unknown na: not available. a P value (two-sided) (0.05/4). age 50 years and for women age 50 years and older. For all but 1 combination of size and grade (Grade IV, cm) in women younger than age 50 years, African American women had a less favorable outcome. DISCUSSION It has been known for years that histologic grade is correlated with survival in women with breast carcinoma. Greenough, 16 who defined three grades based on his analysis of eight histologic variables, reported the first studies in These variables included cell size, glandular formation, epithelial secretion, nuclear size, hyperchromatism, variation in size of the cell and nucleus, and mitotic activity. Since then, many investigators have confirmed the observations of Greenough Clinical trials and population studies have further confirmed the utility of grade as a prognostic factor The SEER data show that African American women have a less favorable 6-year causespecific survival than Caucasian women for nearly every combination of stage and grade, regardless of age. Although these differences did not reach statistical significance for most combinations, they were observed in 11 of the 14 combinations of stage and grade in women younger than age 50 years and in 13 of 14 combinations in women age 50 years and older. These results indicate that breast carcinoma survival rates for African American women are not only less favorable for all stages, they are also less favorable for nearly all combinations of stage and grade. For all stages, African American women, regardless of age, presented with proportionally more Grade III and fewer Grade I or II tumors compared with Caucasian women. This finding indicates that histologic grade, which is a reflection of aggressive tumors, may be an important factor in racial/ethnic disparity. Socioeconomic factors, access to care, less utilization
8 Racial Differences in Histologic Grade/Henson et al. 915 TABLE 4 Comparison of 6-Year Breast Carcinoma Survival Rates by Race, Grade, and Tumor Size for Women Age 50 Years and Older No. of patients 6-yr survival rate White Black White Black Black/White survival rate difference Tumor size 1.0 cm Grade I IV 15, a Grade I Grade II Grade III a Grade IV Unknown Tumor size cm Grade I IV 22, a Grade I Grade II 11, a Grade III Grade IV Unknown Tumor size cm Grade I IV 15, a Grade I Grade II Grade III a Grade IV Unknown Tumor size 5.1 cm Grade I IV a Grade I na na Grade II Grade III Grade IV na na Unknown na: not available. a P value (two-sided) (0.05/4). of screening, treatment differences, and late-stage presentation have been proposed as major causes of disparity. However, the results of the current study suggest that histologic grade also needs to be considered. Grade is evaluated at time of diagnosis and therefore reflects events occurring in the tumor before discovery and treatment. In malignant tumors, grade often correlates with aggressive behavior because higher-grade tumors usually show higher mitotic rates and, by definition, less differentiation. Previous studies have revealed that African American women are more likely to present with estrogen receptor negative tumors, higher S-phase fractions, and higher mitotic activity 12,13 factors usually associated with a less favorable outcome and more aggressive disease. These factors also correlate with higher-grade tumors. When the patterns of grade distribution were considered for all stages combined (Figs. 1, 2), differences were observed between African American women and Caucasian women. Combining stage groups merges all cases into a single group and enables an evaluation of the distribution of grade alone in the study population. For Caucasian women age 50 years and older, the proportion of Grade III tumors was significantly lower than the proportion of Grade II tumors, which differs from the finding for women younger than age 50 years. However, for African American women in both age groups, the proportion of Grade III tumors was significantly higher than the proportion of Grade II tumors. It probably is premature to speculate on the reasons for these different patterns, but they reflect the grade distribution in all stages. Similarly, for each tumor size, African American women consistently had reduced survival compared with Caucasian women. Although tumor size is part of the definition of stage, the data corroborate the reduced survival by stage in African American women. Additional comments should be made. Because
9 916 CANCER September 1, 2003 / Volume 98 / Number 5 the SEER data are derived from widely different areas of the country, pathology practice patterns (including the assignment of grade) will vary in these geographic areas. The assessment of grade is subjective and is a function of education and practice experience, which varies among institutions. However, despite these variations and lack of standardized grading criteria, the black-white differences in outcome were consistent within the combinations of stage and grade. Improved grading systems, such as the Nottingham Combined Histological Grade, have been recommended. 23 The Nottingham system not only provides uniform and quantitative data, it also provides measurements of differentiation, nuclear grade, and mitotic count, which are important parameters in the assessment of tumor aggressiveness. Published studies have shown that survival rates for Grade III and IV tumors are not statistically different. 24 As a result, most pathologists use only three grades for breast carcinoma, combining grades III IV. For this reason, the term grades III IV often is used in the literature to indicate that some pathologists still use Grade IV. Nonetheless, the data clearly indicate that African American women have a less favorable grade distribution at diagnosis for all stages compared with Caucasian women, even when Grade III and Grade IV tumors were combined. Whereas low SES and/or lack of screening may account for late-stage disease and larger tumor size at presentation, it is not so obvious that low SES or lack of screening accounts for the higher-grade tumors seen in African American women compared with Caucasian women. Although all pathologists will agree that high tumor grade indicates a more aggressive type of tumor, grade and other prognostic factors have not been considered a function of delayed diagnosis or lack of screening in contrast to stage and tumor size. Others have observed a higher proportion of Grade III IV breast tumors among African American women compared with Caucasian women. 11,12,25 27 Our data not only confirm these observations but also indicate that higher-grade tumors are found in all stages of breast carcinoma among African American women. For this reason, efforts to detect early-stage disease through screening, although improving survival, may not eliminate the survival disparity because of the higher-grade disease already present in Stage I and II among African American women. REFERENCES 1. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, Bethesda: National Cancer Institute, Siegel R, Blacklow B, Schwartz A. Survival of black women with Stage I and Stage II breast cancer is inferior to survival among white women when treated in the same way and in a single institution. Proc Am Soc Clin Oncol. 1994;13: Diehr P, Yergan J, Chu J, et al. Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals. Med Care. 1989;27: Lyman GH, Kuderer NM, Lyman SL, Cox CE, Reintgen D, Baekey P. Importance of race on breast cancer survival. Ann Surg Oncol. 1997;4: Dayal HH, Power RN, Chiu C. Race and socio-economic status in survival from breast cancer. J Chronic Dis. 1982;35: Vernon SW, Tilley BC, Neale AV, Steinfeldt L. Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer. 1985;55: Smedley BD, Stith A, Nelson AR, editors. Unequal treatment confronting racial and ethnic disparities in health care. Washington: Institute of Medicine, National Academy Press, Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002;95: Gordon NH, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992;135: Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986;76: Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: Chen VW, Correa P, Kurman RJ, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994;3: Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual of staging of cancer, 4th edition. Philadelphia: J.B. Lippincott, Chu KC, Lamar C, Freeman HP. Racial disparities in breast cancer survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003;97: Greenough RB. Varying degrees of malignancy in cancer of the breast. J Cancer Res. 1925;9: Bloom HJG. Prognosis in carcinoma of the breast. Br J Cancer. 1950;4: Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer. 1957;11: Fisher ER, Redmond C, Fisher B, Bass G. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Cancer. 1990;65: Contesso G, Jotti GS, Bonadonna G. Tumor grade as a prognostic factor in primary breast cancer. Eur J Cancer Clin Oncol. 1989;25:
10 Racial Differences in Histologic Grade/Henson et al Davis BW, Gelber RD, Goldhirsh A, et al. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer. 1986;58: Fisher B, Redmond C, Fisher ER, et al. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol. 1988;6: Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer; experience from a large study with long-term follow-up. Histopathology. 1991;19: Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. Cancer. 1991;68: Aziz H, Hussain F, Sohn C, et al. Early onset breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol. 1999;22: Ownby HE, Frederick J, Russo J, et al. Racial differences in breast cancer patients. J Natl Cancer Inst. 1985;75: Simon MS, Severson RK. Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol. 1997;176:S233 S239.
Chapter 13 Cancer of the Female Breast
Lynn A. Gloeckler Ries and Milton P. Eisner INTRODUCTION This study presents survival analyses for female breast cancer based on 302,763 adult cases from the Surveillance, Epidemiology, and End Results
More informationCCSS Concept Proposal Working Group: Biostatistics and Epidemiology
Draft date: June 26, 2010 CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Title: Conditional Survival in Pediatric Malignancies: A Comparison of CCSS and SEER Data Proposed Investigators:
More informationThe projection of short- and long-term survival for. Conditional Survival Among Patients With Carcinoma of the Lung*
Conditional Survival Among Patients With Carcinoma of the Lung* Ray M. Merrill, PhD, MPH; Donald Earl Henson, MD; and Michael Barnes, PhD Objective: One- and 5-year probabilities of survival or death change
More informationBLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER
BLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER Objective: To examine differences between African Americans (Blacks) and non-hispanic Whites in risk of death after diagnosis of laterstage
More informationThe Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER
The Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER 1992-2008 Annie Noone noonea@mail.nih.gov Missy Jamison, Lynn Ries, Brenda Edwards NAACCR 2012 Portland, OR Outline
More informationHysterectomy-Corrected Rates of Endometrial Cancer among Women of Reproductive Age
Hysterectomy-Corrected Rates of Endometrial Cancer among Women of Reproductive Age Annie Noone noonea@mail.nih.gov NAACCR 2017 Albuquerque, NM Motivation Cancer incidence rates are typically calculated
More informationBreast Cancer Trends Among Black and White Women in the United States Ismail Jatoi, William F. Anderson, Sowmya R. Rao, and Susan S.
VOLUME 23 NUMBER 31 NOVEMBER 1 2005 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Breast Cancer Trends Among Black and White Women in the United States Ismail Jatoi, William F. Anderson, Sowmya
More informationMelanoma Surveillance in the United States: Overview of Methods
Melanoma Surveillance in the United States: Overview of Methods Meg Watson, MPH Epidemiologist Epidemiology and Applied Research Branch Division of Cancer Prevention and Control Centers for Disease Control
More informationAvailable online
Available online http://breast-cancer-research.com/content/9/1/r6 Vol 9 No 1 Research article Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
More informationSignificance of Micrometastases on the Survival of Women With T1 Breast Cancer
1234 Significance of Micrometastases on the Survival of Women With T1 Breast Cancer Douglas C. Maibenco, MD, PhD 1 George W. Dombi, PhD 2 Tsui Y. Kau, MS 3 Richard K. Severson, PhD 4 1 Surgical Specialists
More informationNIH Public Access Author Manuscript Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2011 January 1.
NIH Public Access Author Manuscript Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 January ; 19(1): 144 147. doi:10.1158/1055-9965.epi-09-0807. Feasibility Study for Collection
More informationChapter 23 Cancer of the Urinary Bladder
Charles F. Lynch, Jessica A. Davila, and Charles E. Platz Introduction Cancer of the urinary bladder most commonly originates in the urothelium, the epithelium that lines the bladder. During 6, this is
More informationDEFINING RACE/ETHNIC BACKGROUND IN STUDIES OF DISPARITIES
NCI Summit on Cancer Disparities: Workshop on Ancestry Informative Markers Panelists and Agenda 3:15-3:40: 3:40: Lisa Newman, MD, MPH: Univ. of Michigan Cancer Disparities and Racial/Ethnic Background:
More informationKey Words. SEER Cancer Survival Incidence Mortality Prevalence
The Oncologist Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program LYNN A. GLOECKLER RIES, MARSHA E. REICHMAN, DENISE RIEDEL LEWIS, BENJAMIN F. HANKEY, BRENDA
More informationDuring the past 2 decades, an increase in the ageadjusted
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:104 110 Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study JESSICA A. DAVILA* and HASHEM B. EL SERAG*,
More informationSurvival Difference between Non-Hispanic Black and Non-Hispanic White Women with Localized Breast Cancer: The Impact of Guideline-Concordant Therapy
o r i g i n a l c o m m u n i c a t i o n Survival Difference between Non-Hispanic Black and Non-Hispanic White Women with Localized Breast Cancer: The Impact of Guideline-Concordant Therapy Xiaocheng
More informationConditional Colon Cancer Survival in the United States
Research Article imedpub Journals http://www.imedpub.com Colorectal Cancer: Open Access DOI: 10.21767/2471-9943.100020 Abstract Conditional Colon Cancer Survival in the United States Purpose: As long-term
More informationTHE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER
THE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER Casey A. Boyd, Jaime Benarroch, Kristin M. Sheffield, Yimei Han, Catherine D. Cooksley, Taylor S. Riall Department of Surgery The University of Texas Medical
More information6/20/2012. Co-authors. Background. Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy. Age 70 Years
Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy - among Locoregional Breast Cancer Patients Under Age 70 Years Xiao-Cheng Wu, MD, MPH 2012 NAACCR Annual Conference June
More informationA Population-Based Study From the California Cancer Registry. BACKGROUND. Tumor markers are becoming increasingly important in breast cancer
1721 Descriptive Analysis of Estrogen Receptor (ER)- Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer, the So-called Triple-Negative Phenotype A Population-Based
More informationBiological Cure. Margaret R. Stedman, Ph.D. MPH Angela B. Mariotto, Ph.D.
Using Cure Models to Estimate Biological Cure Margaret R. Stedman, Ph.D. MPH Angela B. Mariotto, Ph.D. Data Modeling Branch Surveillance Research Program Division of Cancer Control and Population Sciences
More informationRACIAL DISPARITIES AND TRENDS IN RADIATION THERAPY AFTER BREAST-CONSERVING SURGERY FOR EARLY-STAGE BREAST CANCER IN WOMEN, 1992 TO 2002
RACIAL DISPARITIES AND TRENDS IN RADIATION THERAPY AFTER BREAST-CONSERVING SURGERY FOR EARLY-STAGE BREAST CANCER IN WOMEN, 1992 TO 2002 Objectives: Clinical guidelines recommend that when breast-conserving
More informationChapter Two Incidence & prevalence
Chapter Two Incidence & prevalence Science is the observation of things possible, whether present or past. Prescience is the knowledge of things which may come to pass, though but slowly. LEONARDO da Vinci
More informationCreating prognostic systems for cancer patients: A demonstration using breast cancer
Received: 16 April 2018 Revised: 31 May 2018 DOI: 10.1002/cam4.1629 Accepted: 1 June 2018 ORIGINAL RESEARCH Creating prognostic systems for cancer patients: A demonstration using breast cancer Mathew T.
More informationHEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES. Daniel C.
HEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES Daniel C. West, MD Associate Professor of Pediatrics University of California, Davis
More informationSTUDY. Analysis of the Melanoma Epidemic, Both Apparent and Real
Analysis of the Melanoma Epidemic, Both Apparent and Real Data From the 1973 Through 1994 Surveillance, Epidemiology, and End Results Program Registry Leslie K. Dennis, PhD STUDY Background: The incidence
More informationTemporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
More informationHEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center
HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer
More informationRESEARCH ARTICLE. Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry
DOI:http://dx.doi.org/.734/APJCP.22.3..568 RESEARCH ARTICLE Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry Mai Utada *, Yuko
More informationRare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers,
Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers, 1975-2015 NAACCR 2018 Annual Conference Andrea Ayers, MPH Outline 1. Rare cancer classification 2. Hepatobiliary cancers 3. Key analytic
More informationBreast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C, Heidel RE, Desai P, McLoughlin J, Panella T, Bell
More informationThe TNM classification is a worldwide benchmark for reporting the
1 COMMENTARY The Process for Continuous Improvement of the TNM Classification Mary K. Gospodarowicz, M.D. 1 Daniel Miller, M.D., M.P.H. 2 Patti A. Groome, M.Sc., Ph.D. 3 Frederick L. Greene, M.D. 4 Pamela
More informationA View of Asthma in Oregon
A View of Asthma in Oregon Volume I Issue 2 April 22 In this Issue Disparities in Asthma for African Americans... 1 Disparities in Asthma Hospitalizations and ED Visits for African Americans... 2 Disparities
More informationBreast Cancer Staging
Breast Cancer Staging Symposium on Best Practice in Recording Cancer Stage Royal College of Pathologists 10 June 2011 Dr Gill Lawrence, Director Tel: 0121 415 8129 Fax: 0121 414 7712 Email: gill.lawrence@wmciu.nhs.uk
More informationOncologist. The. Outcomes Research. Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
The Oncologist Outcomes Research Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis DIANNE PULTE, a,b HERMANN BRENNER a a Division of Clinical Epidemiology
More informationHormone receptor and Her2 neu (Her2) analysis
ORIGINAL ARTICLE Impact of Triple Negative Phenotype on Breast Cancer Prognosis Henry G. Kaplan, MD* and Judith A. Malmgren, PhD à *Swedish Cancer Institute at Swedish Medical Center; HealthStat Consulting
More informationΟutcomes for patients who are diagnosed with breast and endometrial cancer
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2013 Οutcomes for patients who are diagnosed with breast and endometrial cancer Tonya M. Martin-Dunlap Washington
More informationP the esophagus may differ from those of squamous
Incidence of Cancer of the Esophagus in the US by Histologic Type PAUL c. YANG, MD, MPH, AND SCOTT DAVIS, PHD' Data from nine US population-based cancer registries participating in the Surveillance, Epidemiology,
More informationAfrican Americans: To screen earlier? Chyke Doubeni, MD, FRCS, MPH
African Americans: To screen earlier? Chyke Doubeni, MD, FRCS, MPH Department of Family Medicine and Community Health Perelman School of Medicine Senior Scholar, Center for Clinical Epidemiology and Biostatistics
More informationThe Decrease in Breast-Cancer Incidence in 2003 in the United States
T h e n e w e ng l a nd j o u r na l o f m e dic i n e s p e c i a l r e p o r t The Decrease in Breast-Cancer Incidence in 23 in the United States Peter M. Ravdin, Ph.D., M.D., Kathleen A. Cronin, Ph.D.,
More informationA Retrospective Analysis of Clinical Utility of AJCC 8th Edition Cancer Staging System for Breast Cancer
Elmer ress Original Article World J Oncol. 2017;8(3):71-75 A Retrospective Analysis of Clinical Utility of AJCC 8th Edition Cancer Staging System for Breast Cancer Hui Hu a, Wei Wei a, Xin Yi a, Ling Xin
More informationRace is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review
Starlard-Davenport et al. SpringerPlus 2013, 2:516 a SpringerOpen Journal RESEARCH Open Access Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review
More informationWho Should Not Receive Chemotherapy? Data From American Databases and Trials
Who Should Not Receive Chemotherapy? Data From American Databases and Trials Monica Morrow, Helen Krontiras The demonstration of the effectiveness of chemotherapy in both premenopausal and postmenopausal
More informationRacial Disparities In The Treatment Of Non-Surgical Patients With Lung Cancer. S Annangi, M G Foreman, H P Ravipati, S Nutakki, E Flenaugh
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 18 Number 1 Racial Disparities In The Treatment Of Non-Surgical Patients With Lung Cancer S Annangi, M G Foreman, H P Ravipati, S Nutakki, E
More informationNIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17.
NIH Public Access Author Manuscript Published in final edited form as: Cancer. 2005 December 15; 104(12 Suppl): 2989 2998. 1999 2001 Cancer Mortality Rates for Asian and Pacific Islander Ethnic Groups
More informationHormone receptor sensitivity in Breast Cancer patients in Pune city of Maharashtra State, India A retrospective study
International Journal of Advanced Biotechnology and Research(IJBR) ISSN 0976-2612, Online ISSN 2278 599X, Vol 6, Issue2, 2015, pp196-202 http://www.bipublication.com Research Article Hormone sensitivity
More informationBreast Cancer in Women from Different Racial/Ethnic Groups
Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State (BCERF) April 2003 Breast Cancer in Women from Different Racial/Ethnic Groups Women of different racial/ethnic
More informationColumbus Affiliate of Susan G. Komen Quantitative Data Report
Columbus Affiliate of Susan G. Komen Quantitative Data Report 2015-2019 Contents 1. Purpose, Intended Use, and Summary of Findings... 4 2. Quantitative Data... 6 2.1 Data Types... 6 2.2 Breast Cancer Incidence,
More informationDepression is associated with impaired recovery from a
Effect of Depression on Diagnosis, Treatment, and Survival of Older Women with Breast Cancer James S. Goodwin, MD, Dong D. Zhang, PhD, and Glenn V. Ostir, PhD OBJECTIVES: To assess the effect of a prior
More informationCancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.
Cancer Causes Control (2008) 19:227 256 DOI 10.1007/s10552-007-9088-3 ORIGINAL PAPER Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Barry A. Miller
More informationOutcomes and Toxicity in African-American and Caucasian Patients in a Randomized Adjuvant Chemotherapy Trial for Colon Cancer
Outcomes and Toxicity in African-American and Caucasian Patients in a Randomized Adjuvant Chemotherapy Trial for Colon Cancer A. David McCollum, Paul J. Catalano, Daniel G. Haller, Robert J. Mayer, John
More informationORIGINAL ARTICLE. Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma
ORIGINAL ARTICLE Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma in the United States Luke M. Richey, BA; Andrew F. Olshan, PhD; Jonathan George, BA; Carol G. Shores, MD, PhD;
More informationAnnual Report to the Nation on the Status of Cancer, , with a Special Feature Regarding Survival
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 7-1-2004 Annual Report to the Nation on the Status of Cancer, 1975 2001,
More informationBreast Cancer Risk and Disease Outcomes for Australian Aboriginal Women
Breast Cancer Risk and Disease Outcomes for Australian Aboriginal Women On the Agenda How frequent is breast cancer in the Indigenous population relative to non- Indigenous people. How do breast cancer
More informationRole of Histological Grading & Mitotic Activity Index in Prognosis of Breast Cancer: A 2 Year Study in a Tertiary Care Health Centre
Original article: Role of Histological Grading & Mitotic Activity Index in Prognosis of Breast Cancer: A 2 Year Study in a Tertiary Care Health Centre 1 AmitVarma, 2 ShilpiDosi, 3 Kamal Malukani, 4 PriyankaKiyawat
More informationUTILIZATION OF SERVICES AMONG ELDERLY CANCER PATIENTS RELATIONSHIP TO AGE, SYMPTOMS, PHYSICAL FUNCTIONING, COMORBIDITY, AND SURVIVAL STATUS
UTILIZATION OF SERVICES AMONG ELDERLY CANCER PATIENTS RELATIONSHIP TO AGE, SYMPTOMS, PHYSICAL FUNCTIONING, COMORBIDITY, AND SURVIVAL STATUS Margot E. Kurtz, PhD; J. C. Kurtz, PhD; Charles W. Given, PhD;
More informationUnstaged cancer in the United States: a population-based study
RESEARCH ARTICLE Open Access Unstaged cancer in the United States: a population-based study Ray M Merrill *, Arielle Sloan, Allison E Anderson and Karem Ryker Abstract Background: The current study examines
More informationBenign breast disease (BBD) is a very common condition,
ORIGINAL ARTICLE Clinical Characteristics of Breast Cancers in African-American Women with Benign Breast Disease: A Comparison to the Surveillance, Epidemiology, and End Results Program Susanna D. Mitro,
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationEthnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,
Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD, MD, Paul Hebert, PhD, Michael C. Iannuzzi, MD, and
More informationFibrolamellar carcinoma (FLC) is a rare primary hepatic
Is Fibrolamellar Different From Hepatocellular? A US Population-Based Study Hashem B. El-Serag 1,2 and Jessica A. Davila 1 There have been no population-based studies of the epidemiology and prognosis
More informationRacial disparities in health outcomes and factors that affect health: Findings from the 2011 County Health Rankings
Racial disparities in health outcomes and factors that affect health: Findings from the 2011 County Health Rankings Author: Nathan R. Jones, PhD University of Wisconsin Carbone Cancer Center Introduction
More informationRacial Variation In Quality Of Care Among Medicare+Choice Enrollees
Racial Variation In Quality Of Care Among Medicare+Choice Enrollees Black/white patterns of racial disparities in health care do not necessarily apply to Asians, Hispanics, and Native Americans. by Beth
More informationColorectal Cancer Demographics and Survival in a London Cancer Network
Cancer Research Journal 2017; 5(2): 14-19 http://www.sciencepublishinggroup.com/j/crj doi: 10.11648/j.crj.20170502.12 ISSN: 2330-8192 (Print); ISSN: 2330-8214 (Online) Colorectal Cancer Demographics and
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationWhat is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*
What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases
More informationTHE DECLINE IN CERVICAL CANCER incidence
Cervical Cancer in North Carolina Incidence, Mortality and Risk Factors Deborah S. Porterfield, MD, MPH; Genevieve Dutton, MA; Ziya Gizlice, PhD THE DECLINE IN CERVICAL CANCER incidence and mortality seen
More informationThe Influence of Race and Ethnicity on End-of-Life Care in the Intensive Care Unit
The Influence of Race and Ethnicity on End-of-Life Care in the Intensive Care Unit Sarah Muni, MD Department of Medicine Chair s Rounds November 10, 2009 Health Disparities Research Clinical appropriateness
More informationPublic Health Democracy: U.S. and Global Health Disparities in Breast Cancer
Public Health Democracy: U.S. and Global Health Disparities in Breast Cancer Doris Browne, MD, MPH Woodrow Wilson Public Policy Scholar Breast and Gynecologic Cancer Research Group NCI, Division of Cancer
More informationRegional Disparities in Ovarian Cancer in the United States
Regional Disparities in Ovarian Cancer in the United States Zhixin Wang 1, Sarah Dilley 2, HyounKyoung G Park 3, Alfred A. Bartolucci 4, Chenguang Wang 5, Warner K. Huh 2,6, Sejong Bae 1,6 1 Division of
More informationLife expectancy in the United States continues to lengthen.
Reduced Mammographic Screening May Explain Declines in Breast Carcinoma in Older Women Robert M. Kaplan, PhD and Sidney L. Saltzstein, MD, MPH wz OBJECTIVES: To examine whether declines in breast cancer
More informationTrends in Leukemia Incidence and Survival in the United States ( )
2229 Trends in Leukemia Incidence and Survival in the United States (1973 1998) Yang Xie, M.D., M.P.H. 1,2 Stella M. Davies, M.D., Ph.D. 1,2 Ying Xiang, M.D. 1,2 Leslie L. Robison, Ph.D. 1,2 Julie A. Ross,
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationExamining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women
Examining Subsequent Occurrence and Outcomes of Estrogen-related Cancers (Breast and Thyroid) in Missouri Women Iris Zachary, PhD, MSHI, CTR; Jeannette Jackson-Thompson, MSPH, PhD; Chester Schmaltz, PhD
More informationGIS FOR COMMUNITY FOOD ACCESS AND ITS RELATIONSHIP TO CANCER. Steve Ramroop 1, Chellani S. Hathorn 2, Peter N. Gichuhi 2, Adelia C.
GIS FOR COMMUNITY FOOD ACCESS AND ITS RELATIONSHIP TO CANCER Steve Ramroop 1, Chellani S. Hathorn 2, Peter N. Gichuhi 2, Adelia C. Bovell-Benjamin 2 1 Department of Mathematics, Physics, Computer Science
More informationSurvival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan
Neurosurg Focus Preview: J Neurosurg 93:December 2000, Click here to return to Table of Contents Survival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan
More informationARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW
doi:10.1016/j.ijrobp.2005.08.024 Int. J. Radiation Oncology Biol. Phys., Vol. xx, No. x, pp. xxx, 2005 Copyright 2005 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/05/$ see front matter
More informationTrends in the Use of Implantable Accelerated Partial Breast Irradiation Therapy for Early Stage Breast Cancer in the United States
Trends in the Use of Implantable Accelerated Partial Breast Irradiation Therapy for Early Stage Breast Cancer in the United States A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY
More informationUse of Endocrine Therapy Data Points # 14
Use of endocrine therapy following diagnosis of ductal carcinoma in situ or early invasive breast cancer Use of Endocrine Therapy Data Points # 14 In 212, approximately 23, women in the United States were
More informationCancer Statistics, 2011
Cancer Statistics, 2011 Cancer Statistics, 2011 The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths Rebecca Siegel, MPH 1 ; Elizabeth Ward, PhD 2 ; Otis Brawley, MD
More informationThe incidence of salivary carcinoma ex pleomorphic adenoma: A SEER database review and review of the literature
ORIGINAL ARTICLE The incidence of salivary carcinoma ex pleomorphic adenoma: A SEER database review and review of the literature Carl Rebhun, Richard O. Wein 1. School of Medicine, Tufts University, United
More informationGood Old clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers q
European Journal of Cancer 40 (2004) 1837 1841 European Journal of Cancer www.ejconline.com Good Old clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
More informationMalignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases
Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Faruk Tas, Sidika Kurul, Hakan Camlica and Erkan Topuz Institute of Oncology, Istanbul University, Istanbul, Turkey Received
More informationRetrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.
Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Goal of the study: 1.To assess whether patients at Truman
More informationRadiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging
Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology
More informationSFMC Breast Cancer Site Study: 2011
SFMC Breast Cancer Site Study: 2011 Introduction Breast cancer is the most frequently diagnosed cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women,
More informationTable of Contents. 2 P age. Susan G. Komen
RHODE ISLAND Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring
More informationOVER the past three decades, numerous randomized
Journal of Gerontology: MEDICAL SCIENCES 2005, Vol. 60A, No. 9, 1137 1144 Copyright 2005 by The Gerontological Society of America Effectiveness of Adjuvant for Node-Positive Operable Breast Cancer in Older
More informationConsensus Guideline on Accelerated Partial Breast Irradiation
Consensus Guideline on Accelerated Partial Breast Irradiation Purpose: To outline the use of accelerated partial breast irradiation (APBI) for the treatment of breast cancer. Associated ASBS Guidelines
More informationOriginal Article. Cancer December 1,
Analysis of Stage and Clinical/Prognostic Factors for Colon and Rectal Cancer From SEER Registries: AJCC and Collaborative Stage Data Collection System Vivien W. Chen, PhD 1 ; Mei-Chin Hsieh, MSPH 1 ;
More informationGreater Atlanta Affiliate of Susan G. Komen Quantitative Data Report
Greater Atlanta Affiliate of Susan G. Komen Quantitative Data Report 2015-2019 Contents 1. Purpose, Intended Use, and Summary of Findings... 4 2. Quantitative Data... 6 2.1 Data Types... 6 2.2 Breast Cancer
More informationChibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article
Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile
More informationCirculating Tumor Cells in non- Metastatic Triple Negative Breast Cancer
Circulating Tumor Cells in non- Metastatic Triple Negative Breast Cancer Carolyn Hall, Ph.D. Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Triple Negative Breast Cancer
More informationThe role of surgical resection in the management of malignant
ORIGINAL ARTICLE Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER])
More informationPost Neoadjuvant therapy: issues in interpretation
Post Neoadjuvant therapy: issues in interpretation Disclosure: Overview D Prognostic features in assessment of post treatment specimens: Tumor size Cellularity Grade Receptors LN Neoadjuvant chemotherapy:
More informationStage III Colon Cancer Susquehanna Cancer Center Warren L Robinson, MD, FACP May 9, 2007
Stage III Colon Cancer Susquehanna Cancer Center 1997-21 Warren L Robinson, MD, FACP May 9, 27 Stage III Colon Cancer Susquehanna Cancer Center 1997-21 Colorectal cancer is the third most common cancer
More informationThe Incidence of Breast Cancer in Examined Biopsies of Breast Masses in Al-Hussain Teaching Hospital in Kerbala
Iraqi JMS Published by Al-Nahrain College of Medicine ISSN 1681-6579 Email: iraqijms@colmed-alnahrain.edu.iq http://www.colmed-alnahrain.edu.iq The Incidence of Breast Cancer in Examined Biopsies of Breast
More informationRacial Treatment Trends in Localized/Regional Prostate Carcinoma:
538 Racial Treatment Trends in Localized/Regional Prostate Carcinoma: 1992 1999 Willie Underwood III, M.D., M.S., M.P.H. 1,2 James Jackson, Ph.D. 3,4 John T. Wei, M.D., M.S. 1 Rodney Dunn, M.S. 1 Edmond
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationConcordance with Breast Cancer Pathology Reporting Practice Guidelines
Concordance with Breast Cancer Pathology Reporting Practice Guidelines Neal W Wilkinson, MD, FACS, Azin Shahryarinejad, MD, Janet S Winston, MD, Nancy Watroba, MPA, Stephen B Edge, MD, FACS BACKGROUND:
More information